Australian clothing company develops face masks from revolutionary fabric

9 April 2020 by Mel Raassina

COVID-19

Non-surgical face masks have been launched by Australian clothing company, Threadsmiths, utilising the revolutionary Polartec® Power Wool from their existing clothing to assist in protecting Australians from exposure to airborne germs.

With many Australian businesses looking for ways to contribute to home-grown manufacturing to assist in the fight against COVID-19, Threadsmiths has stepped up to repurpose their Dumont collection pieces, turning them into face masks by hand in their Melbourne production facility.

Made of a merino wool interior and a synthetic fibre exterior, the face mask features a distinct surface, created to optimise moisture control, breathability, and durability.

https://bit.ly/2UV8Bb5

What do you think?

You must be logged in to post a comment.

Comments

COVID-19

siRNA for Treatment of SARS-CoV-2

RNA interference in animals involves small double-stranded RNA molecules called siRNA. These molecules are valuable tools for studying single gene function in both in vivo and in vitro settings and are also considered a promising class of therapeutics. SiRNA delivery systems fall into two categories: viral and non-viral, including peptides, polymers, and lipids. Studies using synthetic or plasmid-encoded siRNA show its antiviral effects against various viruses, including SARS-CoV. Learn more about siRNA for Treatment of SARS-CoV-2: https://sars-cov-2.creative-biolabs.com/sirna-for-the-treatment-of-sars-cov2.htm

27 September 2023 by Creative Biol... 0 Comments

COVID-19

Vaccine factories in shipping containers

BioNTech, which co-developed a revolutionary mRNA covid-19 vaccine in partnership with Pfizer, hopes to revolutionise another area of pharmaceuticals: vaccine manufacturing. It is developing vaccine factories to sit inside a series of standard metal shipping containers, which it plans to send to parts of the world that lack their own vaccine-manufacturing capabilities-notably Africa. Each facility, BioNTech says, will be able to produce up to 60m doses of covid vaccines and other vaccines each year, and will cost "significantly less" than conventional factories. If so, this could be the future of drugmaking. https://www.economist.com/science-and-technology/biontech-plans-to-make-vaccines-in-shipping-containers/

18 February 2022 by IdeaSpies 0 Comments